SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias sharp selloff is being tied by traders to fears that a Democratic sweep could bring tighter AI regulation or delay data-center projects, alongside broader doubts about AI spending and the sustainability of the chip rally. The community is divided between calling it an AI-bubble unwind and buying the dip on confidence in Nvidias long-term business.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp broad-market selloff is being tied by traders to fears that the Democrats midterm gains could bring tighter AI rules and slow data-center investment, adding pressure to tech-heavy indexes. The community is split between seeing the drop as an overreaction and buying opportunity and expecting further losses amid uncertainty and an unwind in AI-related stocks.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQs sharp tech-led selloff is being tied by traders to fears that the Democratic midterm sweep could bring tighter AI and data-center rules and slow infrastructure spending, with semiconductor weakness adding pressure. The community is split between seeing a deeper correction and AI-trade unwind ahead and viewing the drop as an overreaction or dip-buying opportunity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns sharp selloff is being tied by traders to fears that Democratic gains and calls for tighter AI regulation could slow data-center construction and weaken demand for AI-related chips and memory, amid a broader semiconductor and AI-trade unwind. The community is divided between viewing the drop as an overreaction and dip-buying opportunity because AI memory demand remains strong, and warning that weaker AI spending or a prolonged sector reset could bring further declines.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances quarterly results drew attention with record revenue growth, improved gross margins, and a longer cash runway, but the stock sold off despite the strong report. Traders debate whether broad biotech-market weakness and profit-taking drove the decline or whether concerns about Amtagvis sequential growth and the lung-cancer programs durability and 2027 filing timeline are weighing on sentiment.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A sharp semiconductor and AI-stock selloff has drawn attention to AMD, with traders speculating that post-midterm calls for AI regulation could slow data-center construction, alongside broader concerns about AI spending. The drop contrasts with AMDs strong results and outlook; some traders call it an overreaction and buying opportunity, while others see lingering capex and valuation risks.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention after a sharp selloff alongside AI and optical-infrastructure stocks, with traders citing concerns about hyperscaler spending, AI valuations and the companys upcoming earnings outlook. Some see the decline as an oversold buying opportunity, while others fear more downside and question whether strong results would be enough to reverse the weak sentiment.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unitys quarterly results and outlookfeaturing its first GAAP profit since going public, accelerating Vector advertising growth, and upbeat forward guidanceare driving the rally. Traders are largely celebrating a potential turnaround, while some question whether shares can sustain gains and break through resistance.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff has hammered SOXL, with traders pointing to fears that political shifts could constrain AI and data-center investment, alongside broader worries that the AI trade is unwinding. The funds 3x daily leverage has magnified the drop; traders disagree on whether it marks capitulation and a buying opportunity or further downside ahead.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure as semiconductor traders reassess the AI buildout, weighing concerns that data-center restrictions and doubts about returns on heavy AI spending could slow chip demand. The community is split between fears that the AI trade is unraveling and calls that the selloff is an overreaction, with compute demand still intact.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oscar Health CEO Says Firm On Track For Strongest Financial Performance In History – OSCR Stock On Track To Hit Over 5 Year Highs

Equity

Oscar Health raised its operating earnings forecast to $850 million to $950 million, a third upward revision this year.


Should You Invest in the iShares U.S. Insurance ETF (IAK)?

Insurance ETFs Top Defensive Sector Chart In July As Investors Look To Pivot Slightly From Chips And AI

Insurance ETFs are garnering attention as a defensive play as investors look to hedge against tech and AI.

Likely ETF Winners & Losers From Winter Storm Fern

Winter Storm Fern rattles the United States, lifting heating demand and natural gas prices as UNG stands out while airlines and consumers face headwinds.

UnitedHealth Pledges ACA Profit Rebates Amid Subsidy Debate – But Retail Sees Rally Toward $400 

UnitedHealth Group Inc. plans to rebate profits from its Affordable Care Act plans, also known as Obamacare, to customers in 2026.

AGIG Stock Up Nearly 30% - What Triggered The Rally Today?

Abundia highlighted key objectives for the year, including the acquisition of RPD Technologies by the first-quarter and the completion of Phase 1 at the Cedar Port Innovation Center by second-quarter.

UNH Shares Appear Set For Potential Breakout Above $340 –  Why It’s Crucial For The Stock To Clear This Key Hurdle?

The $340 mark coincides with the stock’s 50-day moving average (50-DMA), currently at around $340.71 – a key hurdle which, if crossed, will be considered as a positive signal for the short term.

iShares Trust - iShares U.S. Insurance ETF

Bullish Sentiment

<ul class="summary-bullets"><li>The company reported a 72% jump in Q3 revenue to $5.12 billion, beating Wall Street estimates of $4.72 billion, according to Fiscal.ai.</li><li>Oscar Health raised its full-year 2026 revenue forecast to $19 billion to $19.3 billion from $18.7 billion to $19 billion.</li><li>The insurer expects FY2026 medical loss ratio to range between 80.5% and 81.5%.</li></ul>Shares of Oscar Health (OSCR) jumped 4.5% in pre-market trading on Thursday, tracking their highest levels since March 2021, after the insurer posted a better-than-expected third-quarter print and raised its full-year outlook for a third time this year.The company reported a 72% jump in third-quarter (Q3) revenue to $5.12 billion, beating Wall Street estimates of $4.72 billion, according to Fiscal.ai. The increase was driven by higher insurance premiums, growing membership, and a $250 million benefit from updated risk adjustment estimates under the Affordable Care Act (ACA) program.<h2 class="st-heading-2">Third Earnings Guidance Raise</h2>Oscar Health raised its full-year 2026 revenue forecast to $19 billion to $19.3 billion from $18.7 billion to $19 billion, and increased its operating earnings outlook to $850 million to $950 million from $600 million to $800 million, marking its third upward revision this year.“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time. Our disciplined pricing, consumer-led products, and technology-powered approach are driving stronger economics and position us to grow market share and expand margin in 2027,” said CEO Mark Bertolini.The company posted net income of $167.3 million, or $0.49 per diluted share, compared with a net loss of $137.5 million, or $0.53 per share, last year. The results comfortably beat analysts’ expectations for a $ 0.17-per-share loss.<h2 class="st-heading-2">Improving MLR In Focus</h2>Oscar Health’s medical loss ratio, which measures the percentage of premium revenue spent on members’ healthcare, improved to 84% from 88.5% a year earlier. The decline indicates the company spent a smaller share of premiums on medical claims.It expects FY2026 medical loss ratio to range between 80.5% and 81.5%, compared with its previous forecast of 81% to 82%.<h2 class="st-heading-2">Retail Turns ‘Extremely Bullish’ On OSCR</h2>Retail sentiment surrounding OSCR on Stocktwits turned ‘extremely bullish’ from ‘bullish’ over the past 24 hours, while message volumes jumped 133%.<img src="https://news.stocktwits-cdn.com/OSCR_5ed13544e9.png" alt="OSCR.png">One user opined Oscar Health is “overdelivering across the board.”<stembedurl>https://stocktwits.com/semi1993/message/668237052</stembedurl><a class="mention" data-mention="$OSCR" data-symbol-id="OSCR" href="https://stocktwits.com/symbol/OSCR" target="_blank">OSCR shares</a> have seen a strong buying interest so far in 2026, gaining about 155%Also read:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/citizens-raises-papzimeos-sales-forecast-after-precigens-q3-topline-beat/cNG10JeR9EH">Citizens Raises Papzimeos Sales Forecast After Precigen’s Q3 Topline Beat – Sees 142% Upside Potential In PGEN Stock</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Oscar Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China.  (Photo illustration by Cheng Xin/Getty Images)

Oscar Health raised its operating earnings forecast to $850 million to $950 million, a third upward revision this year.

Current Price	$153.20
Prev Close	$153.25
Open	$154.72
Dividend Yield	N/A
50-Day Moving Average	$143.49
Beta	N/A
Avg. Volume	88,412.36
PE Ratio	N/A

52-Week High	$153.28
52-Week Low	$125.38
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IAK Fundamentals